Trials / Conditions / Relapsed Acute Myeloid Leukemia (AML)
Relapsed Acute Myeloid Leukemia (AML)
3 registered clinical trials studyying Relapsed Acute Myeloid Leukemia (AML) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS NCT07347418 | University of Colorado, Denver | Phase 1 |
| Active Not Recruiting | Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS NCT06846606 | Auron Therapeutics, Inc. | Phase 1 |
| Completed | A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome NCT03787498 | Opna Bio LLC | Phase 1 |